GlassScriptPhysician profile
Casey Prammanasudh
NPI 1114314622
$581.02
in general payments reported to CMS, 2019-2025
16 companies · $37.19 in 2025
The $37.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $126 · 2023: $128 · 2024: $186 · 2025: $37.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.16 | 2021-2023 | |
| Astellas Pharma US INC | $114.98 | 2023-2024 | Veozah |
| Davol INC. | $61.16 | 2024 | Arista Ah Flexitip |
| Shield Therapeutics INC | $42.10 | 2024-2025 | |
| Pfizer INC. | $28.12 | 2023 | |
| Mylan Pharmaceuticals INC. | $25.94 | 2022 | |
| Therapeuticsmd, INC. | $22.29 | 2021 | |
| Medtronic, INC. | $18.03 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.43 | 2021 | |
| Hologic Sales and Service, LLC | $17.20 | 2023 | Novasure |
| Phathom Pharmaceuticals, INC. | $16.53 | 2024 | Voquezna |
| Exeltis, USA INC. | $16.19 | 2023 | Slynd |
| Olympus America INC. | $16.03 | 2023 | Olympus |
| Dexcom, INC. | $15.88 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $15.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Prammanasudh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.